Olaratumab for the treatment of advanced soft tissue sarcoma.

about

Olaratumab for the treatment of advanced soft tissue sarcoma.

Item

http://www.wikidata.org/entity/Q47729241

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Olaratumab for the treatment of advanced soft tissue sarcoma.

@en

Olaratumab for the treatment of advanced soft tissue sarcoma.

@nl

type

Item

label

Olaratumab for the treatment of advanced soft tissue sarcoma.

@en

Olaratumab for the treatment of advanced soft tissue sarcoma.

@nl

prefLabel

Olaratumab for the treatment of advanced soft tissue sarcoma.

@en

Olaratumab for the treatment of advanced soft tissue sarcoma.

@nl

P1476

Olaratumab for the treatment of advanced soft tissue sarcoma.

@en

P2093

Avudaiappan Maran

http://www.w3.org/2001/XMLSchema#string

Scott H Okuno

http://www.w3.org/2001/XMLSchema#string

Steven I Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor

Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives

Involvement of platelet-derived growth factor in disease: development of specific antagonists.

PDGFR-alpha as a potential therapeutic target in uterine sarcomas.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove.

Preclinical and clinical results with the natural marine product ET-743.

P304

883-887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737140.2017.1374857

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28862476

http://www.w3.org/2001/XMLSchema#string